Literature DB >> 21507970

Conserved GXXXG- and S/T-like motifs in the transmembrane domains of NS4B protein are required for hepatitis C virus replication.

Qingxia Han1, Jason Aligo, David Manna, Kerry Belton, Sree V Chintapalli, Yoojin Hong, Randen L Patterson, Damian B van Rossum, Kouacou V Konan.   

Abstract

Hepatitis C virus (HCV) nonstructural protein 4B (NS4B) is an integral membrane protein, which plays an important role in the organization and function of the HCV replication complex (RC). Although much is understood about its amphipathic N-terminal and C-terminal domains, we know very little about the role of the transmembrane domains (TMDs) in NS4B function. We hypothesized that in addition to anchoring NS4B into host membranes, the TMDs are engaged in intra- and intermolecular interactions required for NS4B structure/function. To test this hypothesis, we have engineered a chimeric JFH1 genome containing the Con1 NS4B TMD region. The resulting virus titers were greatly reduced from those of JFH1, and further analysis indicated a defect in genome replication. We have mapped this incompatibility to NS4B TMD1 and TMD2 sequences, and we have defined putative TMD dimerization motifs (GXXXG in TMD2 and TMD3; the S/T cluster in TMD1) as key structural/functional determinants. Mutations in each of the putative motifs led to significant decreases in JFH1 replication. Like most of the NS4B chimeras, mutant proteins had no negative impact on NS4B membrane association. However, some mutations led to disruption of NS4B foci, implying that the TMDs play a role in HCV RC formation. Further examination indicated that the loss of NS4B foci correlates with the destabilization of NS4B protein. Finally, we have identified an adaptive mutation in the NS4B TMD2 sequence that has compensatory effects on JFH1 chimera replication. Taken together, these data underscore the functional importance of NS4B TMDs in the HCV life cycle.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507970      PMCID: PMC3126491          DOI: 10.1128/JVI.02298-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  77 in total

1.  Mutations of conserved glycine residues within the membrane-spanning domain of human immunodeficiency virus type 1 gp41 can inhibit membrane fusion and incorporation of Env onto virions.

Authors:  Kosuke Miyauchi; Rachael Curran; Erin Matthews; Jun Komano; Tyuji Hoshino; Don M Engelman; Zene Matsuda
Journal:  Jpn J Infect Dis       Date:  2006-04       Impact factor: 1.362

2.  Palmitoylation and polymerization of hepatitis C virus NS4B protein.

Authors:  Guann-Yi Yu; Ki-Jeong Lee; Lu Gao; Michael M C Lai
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  Mutations of the Hepatitis C virus protein NS4B on either side of the ER membrane affect the efficiency of subgenomic replicons.

Authors:  Hannah Lindström; Marika Lundin; Sandra Häggström; Mats A A Persson
Journal:  Virus Res       Date:  2006-06-30       Impact factor: 3.303

4.  Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines.

Authors:  B Wölk; D Sansonno; H G Kräusslich; F Dammacco; C M Rice; H E Blum; D Moradpour
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Functional domains and dynamic assembly of the peroxin Pex14p, the entry site of matrix proteins.

Authors:  Ryota Itoh; Yukio Fujiki
Journal:  J Biol Chem       Date:  2006-02-02       Impact factor: 5.157

6.  GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42.

Authors:  Lisa-Marie Munter; Philipp Voigt; Anja Harmeier; Daniela Kaden; Kay E Gottschalk; Christoph Weise; Rüdiger Pipkorn; Michael Schaefer; Dieter Langosch; Gerd Multhaup
Journal:  EMBO J       Date:  2007-03-01       Impact factor: 11.598

7.  Transmembrane domains of hepatitis C virus envelope glycoproteins: residues involved in E1E2 heterodimerization and involvement of these domains in virus entry.

Authors:  Yann Ciczora; Nathalie Callens; François Penin; Eve-Isabelle Pécheur; Jean Dubuisson
Journal:  J Virol       Date:  2006-12-13       Impact factor: 5.103

8.  Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus.

Authors:  MinKyung Yi; Yinghong Ma; Jeremy Yates; Stanley M Lemon
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  Participation of rab5, an early endosome protein, in hepatitis C virus RNA replication machinery.

Authors:  Michelle Stone; Shuaizheng Jia; Won Do Heo; Tobias Meyer; Kouacou V Konan
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

10.  Persistent hepatitis C virus infection in vitro: coevolution of virus and host.

Authors:  Jin Zhong; Pablo Gastaminza; Josan Chung; Zania Stamataki; Masanori Isogawa; Guofeng Cheng; Jane A McKeating; Francis V Chisari
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

View more
  19 in total

Review 1.  Lipids and RNA virus replication.

Authors:  Kouacou V Konan; Lorena Sanchez-Felipe
Journal:  Curr Opin Virol       Date:  2014-09-28       Impact factor: 7.090

2.  Modulation of hepatitis C virus genome replication by glycosphingolipids and four-phosphate adaptor protein 2.

Authors:  Irfan Khan; Divya S Katikaneni; Qingxia Han; Lorena Sanchez-Felipe; Kentaro Hanada; Rebecca L Ambrose; Jason M Mackenzie; Kouacou V Konan
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

3.  Hepatitis C Virus NS4B Can Suppress STING Accumulation To Evade Innate Immune Responses.

Authors:  Guanghui Yi; Yahong Wen; Chang Shu; Qingxia Han; Kouacou V Konan; Pingwei Li; C Cheng Kao
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

4.  Glycine Zipper Motifs in Hepatitis C Virus Nonstructural Protein 4B Are Required for the Establishment of Viral Replication Organelles.

Authors:  David Paul; Vanesa Madan; Omar Ramirez; Maja Bencun; Ina Karen Stoeck; Vlastimil Jirasko; Ralf Bartenschlager
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

5.  The membrane- and soluble-protein helix-helix interactome: similar geometry via different interactions.

Authors:  Shao-Qing Zhang; Daniel W Kulp; Chaim A Schramm; Marco Mravic; Ilan Samish; William F DeGrado
Journal:  Structure       Date:  2015-02-19       Impact factor: 5.006

6.  Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.

Authors:  Kyoko Saito; Yoshitaka Shirasago; Tetsuro Suzuki; Hideki Aizaki; Kentaro Hanada; Takaji Wakita; Masahiro Nishijima; Masayoshi Fukasawa
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

7.  Selection of classical swine fever virus with enhanced pathogenicity reveals synergistic virulence determinants in E2 and NS4B.

Authors:  Tomokazu Tamura; Yoshihiro Sakoda; Fumi Yoshino; Takushi Nomura; Naoki Yamamoto; Yuka Sato; Masatoshi Okamatsu; Nicolas Ruggli; Hiroshi Kida
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

8.  Modulation of hepatitis C virus genome encapsidation by nonstructural protein 4B.

Authors:  Qingxia Han; David Manna; Kerry Belton; Richard Cole; Kouacou V Konan
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

9.  Preclinical Characterization and In Vivo Efficacy of GSK8853, a Small-Molecule Inhibitor of the Hepatitis C Virus NS4B Protein.

Authors:  Jeffrey J Pouliot; Michael Thomson; Mi Xie; Joseph Horton; John Johnson; David Krull; Amanda Mathis; Yoshio Morikawa; Derek Parks; Richard Peterson; Takashi Shimada; Elizabeth Thomas; Jessica Vamathevan; Stephanie Van Horn; Zhiping Xiong; Robert Hamatake; Andrew J Peat
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

Review 10.  Structures of hepatitis C virus nonstructural proteins required for replicase assembly and function.

Authors:  Meigang Gu; Charles M Rice
Journal:  Curr Opin Virol       Date:  2013-04-16       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.